158 related articles for article (PubMed ID: 35688944)
1. PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma.
Liu Y; Ouyang L; Mao C; Chen Y; Li T; Liu N; Wang Z; Lai W; Zhou Y; Cao Y; Liu S; Liang Y; Wang M; Liu S; Chen L; Shi Y; Xiao D; Tao Y
Oncogene; 2022 Jul; 41(27):3570-3583. PubMed ID: 35688944
[TBL] [Abstract][Full Text] [Related]
2. E3 ubiquitin ligase CHIP interacts with transferrin receptor 1 for degradation and promotes cell proliferation through inhibiting ferroptosis in hepatocellular carcinoma.
Shao M; Qi K; Wang L; Yu X; Zhang Q; Yu L; Wang L; Yang C; Fan L
Cell Signal; 2024 Jun; 118():111148. PubMed ID: 38521179
[TBL] [Abstract][Full Text] [Related]
3. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma.
Chen Q; Zheng W; Guan J; Liu H; Dan Y; Zhu L; Song Y; Zhou Y; Zhao X; Zhang Y; Bai Y; Pan Y; Zhang J; Shao C
Cell Death Differ; 2023 Jan; 30(1):137-151. PubMed ID: 35995846
[TBL] [Abstract][Full Text] [Related]
4. ZNF498 promotes hepatocellular carcinogenesis by suppressing p53-mediated apoptosis and ferroptosis via the attenuation of p53 Ser46 phosphorylation.
Zhang X; Zheng Q; Yue X; Yuan Z; Ling J; Yuan Y; Liang Y; Sun A; Liu Y; Li H; Xu K; He F; Wang J; Wu J; Zhao C; Tian C
J Exp Clin Cancer Res; 2022 Feb; 41(1):79. PubMed ID: 35227287
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11.
Fan Z; Yang G; Zhang W; Liu Q; Liu G; Liu P; Xu L; Wang J; Yan Z; Han H; Liu R; Shu M
J Cell Mol Med; 2021 Nov; 25(21):10197-10212. PubMed ID: 34609072
[TBL] [Abstract][Full Text] [Related]
6. TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin‒proteasome system.
Zhang J; Yimamu M; Cheng Z; Ji J; Wu L; Feng J; Xu X; Wu J; Guo C
Free Radic Biol Med; 2024 Jul; 219():31-48. PubMed ID: 38614226
[TBL] [Abstract][Full Text] [Related]
7. Aspirin triggers ferroptosis in hepatocellular carcinoma cells through restricting NF-κB p65-activated SLC7A11 transcription.
Wang YF; Feng JY; Zhao LN; Zhao M; Wei XF; Geng Y; Yuan HF; Hou CY; Zhang HH; Wang GW; Yang G; Zhang XD
Acta Pharmacol Sin; 2023 Aug; 44(8):1712-1724. PubMed ID: 36829052
[TBL] [Abstract][Full Text] [Related]
8. RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA.
Wang Q; Guo Y; Wang W; Liu B; Yang G; Xu Z; Li J; Liu Z
Exp Cell Res; 2021 Feb; 399(1):112453. PubMed ID: 33358859
[TBL] [Abstract][Full Text] [Related]
9. LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination.
Zhang B; Bao W; Zhang S; Chen B; Zhou X; Zhao J; Shi Z; Zhang T; Chen Z; Wang L; Zheng X; Chen G; Wang Y
Cell Death Dis; 2022 Aug; 13(8):734. PubMed ID: 36008384
[TBL] [Abstract][Full Text] [Related]
10. ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma.
Huang W; Chen K; Lu Y; Zhang D; Cheng Y; Li L; Huang W; He G; Liao H; Cai L; Tang Y; Zhao L; Pan M
Neoplasia; 2021 Dec; 23(12):1227-1239. PubMed ID: 34768109
[TBL] [Abstract][Full Text] [Related]
11. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
[No Abstract] [Full Text] [Related]
12. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
[TBL] [Abstract][Full Text] [Related]
13. COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma.
Yang M; Wu X; Hu J; Wang Y; Wang Y; Zhang L; Huang W; Wang X; Li N; Liao L; Chen M; Xiao N; Dai Y; Liang H; Huang W; Yuan L; Pan H; Li L; Chen L; Liu L; Liang L; Guan J
J Hepatol; 2022 May; 76(5):1138-1150. PubMed ID: 35101526
[TBL] [Abstract][Full Text] [Related]
14. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
[TBL] [Abstract][Full Text] [Related]
15. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
[TBL] [Abstract][Full Text] [Related]
16. A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma.
Feng Y; Zhang Y; Cai Y; Liu R; Lu M; Li T; Fu Y; Guo M; Huang H; Ou Y; Chen Y
Cell Death Dis; 2020 Feb; 11(2):89. PubMed ID: 32015333
[TBL] [Abstract][Full Text] [Related]
17. Minichromosome maintenance protein family member 6 mediates hepatocellular carcinoma progression by recruiting UBE3A to induce P53 ubiquitination.
Zhang X; Bian S; Ni Y; Zhou L; Yang C; Zhang C; Sun X; Xu N; Xu S; Wang Y; Gu S; Zheng W
Int J Biol Macromol; 2023 Sep; 248():125854. PubMed ID: 37460074
[TBL] [Abstract][Full Text] [Related]
18. LINC00942 inhibits ferroptosis and induces the immunosuppression of regulatory T cells by recruiting IGF2BP3/SLC7A11 in hepatocellular carcinoma.
Jin D; Hui Y; Liu D; Li N; Leng J; Wang G; Wang Q; Lu Z
Funct Integr Genomics; 2024 Feb; 24(1):29. PubMed ID: 38353724
[TBL] [Abstract][Full Text] [Related]
19. Dihydroartemisinin Induces Ferroptosis in HCC by Promoting the Formation of PEBP1/15-LO.
Su Y; Zhao D; Jin C; Li Z; Sun S; Xia S; Zhang Y; Zhang Z; Zhang F; Xu X; Shao J; Zhang B; Zheng S
Oxid Med Cell Longev; 2021; 2021():3456725. PubMed ID: 34925691
[TBL] [Abstract][Full Text] [Related]
20. UBAP2 negatively regulates the invasion of hepatocellular carcinoma cell by ubiquitinating and degradating Annexin A2.
Bai DS; Wu C; Yang LX; Zhang C; Zhang PF; He YZ; Cai JB; Song ZJ; Dong ZR; Huang XY; Ke AW; Shi GM
Oncotarget; 2016 May; 7(22):32946-55. PubMed ID: 27121050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
